Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension

S. Pedersen (LONDON, United Kingdom), Q. Toe (LONDON, United Kingdom), S. Wort (LONDON, United Kingdom), G. Quinlan* (LONDON, United Kingdom), L. Ramakrishnan* (LONDON, United Kingdom)

Source: International Congress 2018 – Experimental research in pulmonary hypertension
Session: Experimental research in pulmonary hypertension
Session type: Thematic Poster
Number: 3062
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pedersen (LONDON, United Kingdom), Q. Toe (LONDON, United Kingdom), S. Wort (LONDON, United Kingdom), G. Quinlan* (LONDON, United Kingdom), L. Ramakrishnan* (LONDON, United Kingdom). Stabilised ferroportin activity affects pulmonary vascular cells responses: implications for pulmonary hypertension. 3062

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018

Endothelial-derived MIF contributes to pulmonary endothelial cell proliferation in human pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

Pulmonary artery endothelial cell exposure to hepcidin affects BMP-signalling; relevance to vascular remodelling in PAH
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


MIF/CD74 contributes to the endothelial pro-inflammatory phenotype in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Is pulmonary hypertension associated with a leakage or an activation of endothelial cells?
Source: Eur Respir J 2003; 22: Suppl. 45, 74s
Year: 2003

Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
Source: Eur Respir J 2011; 38: 1453-1460
Year: 2011



Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021
Year: 2021



Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020
Year: 2021



Potential contribution of precursor cells to vascular remodeling in the AdTGF-β1 model of lung fibrosis and pulmonary hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011

A central role for nuclear factor of activated T cells (NFAT) in human pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006


IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010

Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
Year: 2021



CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension
Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020
Year: 2020



Role of c-Abelson in the loss of genome integrity in endothelial cells in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Year: 2020


Regulation of connexins by hypoxia in rat pulmonary vascular cells in an in vitro model of pulmonary hypertension
Source: International Congress 2017 – Experimental PH
Year: 2017